For a startup built on a deceptively simple idea — let doctors be doctors — Abridge has become one of the most valuable AI companies ever born in Pittsburgh. In June 2025, the Downtown Pittsburgh startup announced a $300 million Series E funding round led by Andreessen Horowitz and Khosla Ventures, pushing its valuation to $5.3 billion and cementing its place as the city's most consequential technology success story in a generation.
Abridge's product works quietly. When a physician walks into an exam room, the AI listens to the conversation and, by the time the appointment ends, a structured clinical note draft is ready. No dictating into a recorder. No staying late to type. The system draws on a proprietary dataset of more than 1.5 million medical encounters, and it was built by Dr. Shiv Rao, Abridge's CEO and co-founder, from his own frustration as a practicing cardiologist who spent too many evenings writing notes instead of being present for patients.
"Every medical conversation is rich with the signals our healthcare system depends on. Abridge activates those signals in the background, silently handling the complexity so clinicians can focus on the human moments that matter."
Dr. Shiv Rao, CEO & Co-Founder, Abridge
The numbers behind Abridge's growth are hard to ignore. The company is now deployed in more than 150 health systems across the United States, a 50 percent increase from just four months earlier when a $250 million Series D round closed at a $2.75 billion valuation. This year, Abridge's technology is on pace to support an estimated 50 million medical conversations. The platform can automate up to 91 percent of the work involved in creating medical notes, translating to roughly 70 hours saved per clinician each month.
The scale of the raise carries particular weight in the context of Pittsburgh's startup ecosystem. In the first quarter of 2025, Abridge accounted for nearly half of the entire Pittsburgh region's venture capital haul, which set a decade-high record of $689 million. Over its seven-year history, Abridge has now raised more than $800 million in total. The additional funding will go toward scaling the platform's capabilities, eliminating friction between clinical teams and billing departments, and expanding partnerships with health systems that are looking to reduce the administrative burden that has driven physician burnout to crisis levels nationwide.
Founded in 2018 and long anchored in Downtown Pittsburgh near the University of Pittsburgh Medical Center — where Dr. Rao trained and practiced — Abridge is beginning to extend its footprint. The company has announced plans to hire in San Francisco, drawn by the engineering talent concentrated there. But Pittsburgh remains its headquarters, and local hiring continues. Each new role the company fills in the city is another data point in Pittsburgh's broader story of retaining the AI talent its universities produce rather than watching it leave for the coasts.
For a city that spent decades rebuilding its identity from steel to software, Abridge's trajectory means something beyond a funding announcement. It is evidence that Pittsburgh can originate world-class AI companies, not merely inspire them before they relocate. With Carnegie Mellon and the University of Pittsburgh continuing to produce machine learning and biomedical AI talent at a world-class rate — and with companies like Skild AI, Duolingo, and now Abridge posting billion-dollar valuations — Pittsburgh's claim as a leading AI hub is no longer an aspiration. It is a fact, told in the numbers.